Literature DB >> 8503189

Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.

J Park1, C D Morrow.   

Abstract

The expression of the pol gene of human immunodeficiency virus type 1 (HIV-1) occurs by a ribosomal frameshift between the gag and the pol genes. The Gag-Pol polyprotein is produced at levels of 5 to 10% of that of the Gag protein, and is incorporated into virions to provide the viral protease, reverse transcriptase, and integrase which are essential for replication. The mechanism(s) by which the Gag-Pol polyprotein are targeted to the HIV virion is unknown, although it is believed to be via an interaction with the Gag protein. To further explore the mechanism by which the Gag-Pol polyprotein is incorporated into virions, we have constructed a mutation which changes an aspartic acid in the protease active site to asparagine (pHXB2pro-); a four-amino-acid insertion into the protease gene (pHXB2Smal); and insertion of translational termination codons in the protease gene following the gag gene (pHXB55). Transfection of these proviral genomes into COS-1 cells resulted in intracellular expression of only Pr55gag, demonstrating the inactivation of the viral protease. The expression of Pr55gag was evident in cells transfected with pHXB2pro- during a short pulse and first 3 hr of chase period, whereas at later times the intracellular levels of Pr55gag were greatly reduced. In contrast, the intracellular Pr55gag expressed from transfection of pHXB2Smal or pHXB55 were evident even after 6- or 12-hr chase times. To ascertain the effects of the mutations on the assembly and release of viruslike particles, the supernatants from the transfected cells were analyzed for the presence of Pr55gag. The release of Pr55gag from cells transfected with pHXB2pro- occurred as early as 1 hr following chase period, and increased for up to 3 hr. In contrast, reduced levels of Pr55gag were detected in the medium from cells transfected with pHXB2Smal or pHXB55. Subcellular fractionation studies demonstrated that the Pr55gag expressed from transfection of pHXB2pro- was rapidly targeted to intracellular membranes, while the majority of the Pr55gag expressed from transfection of pHXB2Smal or pHXB55 was distributed evenly between the cytoplasm and membrane fractions. Finally, the released viruslike particles obtained from the transfection of proviral genome pHXB2pro- were stable to mild detergent treatment, whereas particles obtained from transfection of pHXB2Smal and pHXB55 were relatively unstable. These results demonstrate that subtle changes in the Gag-Pol polyprotein of HIV-1 can have significant effects on the assembly and physical stability of the released virus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503189     DOI: 10.1006/viro.1993.1328

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.

Authors:  P Sova; D J Volsky; L Wang; W Chao
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.

Authors:  K Wiegers; G Rutter; H Kottler; U Tessmer; H Hohenberg; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 3.  HIV-1 antiretroviral drug therapy.

Authors:  Eric J Arts; Daria J Hazuda
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

4.  Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.

Authors:  R Welker; H Hohenberg; U Tessmer; C Huckhagel; H G Kräusslich
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 5.  The gag proteins of human immunodeficiency virus type 1: mechanisms of virus assembly and possibilities for interference.

Authors:  S Modrow; B Kattenbeck; A von Poblotzki; M Niedrig; R Wagner; H Wolf
Journal:  Med Microbiol Immunol       Date:  1994-09       Impact factor: 3.402

6.  Maturation of the Gag core decreases the stability of retroviral lipid membranes.

Authors:  Candice Davidoff; Riley J Payne; Sharon H Willis; Benjamin J Doranz; Joseph B Rucker
Journal:  Virology       Date:  2012-09-17       Impact factor: 3.616

7.  HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity.

Authors:  Barbara Müller; Maria Anders; Hisashi Akiyama; Sonja Welsch; Bärbel Glass; Krisztina Nikovics; Francois Clavel; Hanna-Mari Tervo; Oliver T Keppler; Hans-Georg Kräusslich
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

8.  Genetic analysis of the human immunodeficiency virus type 1 integrase protein.

Authors:  C G Shin; B Taddeo; W A Haseltine; C M Farnet
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA.

Authors:  A H Kaplan; P Krogstad; D J Kempf; D W Norbeck; R Swanstrom
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

10.  Effects of blocking individual maturation cleavages in murine leukemia virus gag.

Authors:  Masamichi Oshima; Delphine Muriaux; Jane Mirro; Kunio Nagashima; Kelly Dryden; Mark Yeager; Alan Rein
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.